Published in Hum Mol Genet on November 01, 2001
22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci (2010) 2.54
The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull (2009) 2.38
Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A (2006) 2.03
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull (2009) 1.45
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr Bull (2009) 1.44
A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci U S A (2003) 1.42
The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology (2007) 1.31
Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol Psychiatry (2013) 1.22
Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex. Neural Dev (2011) 1.16
The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci (2010) 1.16
Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics (2006) 1.14
Cognition in mouse models of schizophrenia susceptibility genes. Schizophr Bull (2009) 1.11
Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet (2011) 1.11
Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome. J Neurosci (2010) 1.06
Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model. Proc Natl Acad Sci U S A (2013) 1.01
A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. Proc Natl Acad Sci U S A (2005) 0.99
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov (2012) 0.97
Overlapping deletions spanning the proximal two-thirds of the mouse t complex. Mamm Genome (2003) 0.94
Development of animal models for schizophrenia. Dis Model Mech (2010) 0.93
Molecular mechanisms in 22q11 deletion syndrome. Schizophr Bull (2011) 0.87
Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum Brain Mapp (2007) 0.87
Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Mol Cell Neurosci (2011) 0.86
A 1.1-Mb segmental deletion on the X chromosome causes meiotic failure in male mice. Biol Reprod (2013) 0.85
Analysis of TBX1 variation in patients with psychotic and affective disorders. Mol Med (2007) 0.85
Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development. Prog Neurobiol (2015) 0.85
Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome. Transl Psychiatry (2012) 0.84
A defect in early myogenesis causes Otitis media in two mouse models of 22q11.2 Deletion Syndrome. Hum Mol Genet (2014) 0.82
Neural phenotypes of common and rare genetic variants. Biol Psychol (2008) 0.81
Animal models of psychiatric disorders that reflect human copy number variation. Neural Plast (2012) 0.81
Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS. Cereb Cortex (2013) 0.80
Hearing loss in a mouse model of 22q11.2 Deletion Syndrome. PLoS One (2013) 0.79
Neuronal migration abnormalities and its possible implications for schizophrenia. Front Neurosci (2015) 0.78
PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome. Psychopharmacology (Berl) (2015) 0.77
Microendophenotypes of psychiatric disorders: phenotypes of psychiatric disorders at the level of molecular dynamics, synapses, neurons, and neural circuits. Curr Mol Med (2015) 0.76
Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms. Brain Res (2015) 0.75
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. J Psychiatry Neurosci (2017) 0.75
Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome. Cereb Cortex (2016) 0.75
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol (2017) 0.75
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev (1995) 4.87
Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (2001) 4.41
Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet (1997) 3.20
Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet (1998) 3.18
A randomized trial of a family physician intervention for smoking cessation. JAMA (1988) 3.03
Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature (1999) 2.60
Origin of human chromosome 2: an ancestral telomere-telomere fusion. Proc Natl Acad Sci U S A (1991) 2.54
Improved telomere detection using a telomere repeat probe (TTAGGG)n generated by PCR. Nucleic Acids Res (1991) 2.52
Simultaneous visualization of seven different DNA probes by in situ hybridization using combinatorial fluorescence and digital imaging microscopy. Proc Natl Acad Sci U S A (1992) 2.32
Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav (2005) 2.22
The use of behavioral test batteries: effects of training history. Physiol Behav (2001) 2.20
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet (2000) 2.17
Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry (2002) 2.04
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet (1996) 1.93
Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J Clin Microbiol (2001) 1.80
Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet (1993) 1.76
Medicine and health care: a marriage of necessity. CMAJ (1994) 1.74
Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum Mol Genet (1997) 1.70
Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc Natl Acad Sci U S A (1995) 1.67
Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem (1997) 1.59
Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol (1999) 1.57
Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. Am J Hum Genet (1996) 1.56
Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization. Genomics (1993) 1.55
Low-copy-number repeat sequences flank the DiGeorge/velo-cardio-facial syndrome loci at 22q11. Hum Mol Genet (1993) 1.50
Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet (1995) 1.49
Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet (1995) 1.43
Difficult hospital discharges in internal medicine wards. Intern Emerg Med (2007) 1.42
Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci U S A (1994) 1.42
Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization. Am J Med Genet (1994) 1.35
Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome. Am J Hum Genet (1996) 1.31
Diagnosis of bilateral abdominal cryptorchidism by laparoscopy. Endoscopy (1976) 1.28
A human chromosome 9-specific alphoid DNA repeat spatially resolvable from satellite 3 DNA by fluorescent in situ hybridization. Genomics (1991) 1.27
DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene (1998) 1.26
Effect of tourniquet use on activation of coagulation in total knee replacement. Clin Orthop Relat Res (2000) 1.25
Schizophrenia and chromosomal deletions within 22q11.2. Am J Hum Genet (1995) 1.21
Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region. Hum Mol Genet (2001) 1.16
The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum Mol Genet (1995) 1.15
A 12-Mb complete coverage BAC contig map in human chromosome 16p13.1-p11.2. Genome Res (1999) 1.14
Hormone-modulated rRNA gene activity is visualized by selective staining of the NOs. Cell Biol Int Rep (1985) 1.12
De novo tandem duplication of chromosome segment 22q11-q12: clinical, cytogenetic, and molecular characterization. Am J Med Genet (1995) 1.10
The Insall-Burstein II prosthesis: a 5- to 9-year follow-up study in osteoarthritic knees. J Arthroplasty (2002) 1.09
Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella typhimurium DT104. Vet Rec (2000) 1.07
Human genes encoding the voltage-dependent anion channel (VDAC) of the outer mitochondrial membrane: mapping and identification of two new isoforms. Genomics (1994) 1.06
A smoking cessation intervention program for family physicians. CMAJ (1987) 1.04
Quantification by flow cytometry of chromosome-17 deletions in Smith-Magenis syndrome patients. Hum Genet (1996) 1.02
A family physician smoking cessation program: an evaluation of the role of follow-up visits. Am J Prev Med (1992) 1.01
Investigation of the genetic diversity among isolates of Salmonella enterica serovar Dublin from animals and humans from England, Wales and Ireland. J Appl Microbiol (2002) 1.01
Disease severity and health-related quality of life across different chronic conditions. J Am Geriatr Soc (2000) 1.00
Duplication 3q syndrome: molecular delineation of the critical region. Am J Med Genet (1995) 1.00
Identification and molecular characterization of de novo translocation t(8;14)(q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet (2001) 1.00
Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX1 gene. JAMA (1995) 0.99
A transcription map in the CATCH22 critical region: identification, mapping, and ordering of four novel transcripts expressed in heart. Genomics (1996) 0.98
Smoking cessation in primary care. A randomized controlled trial of nicotine-bearing chewing gum. J Fam Pract (1989) 0.98
Methylation of the 5' flanking sequences of the ribosomal DNA in human cell lines and in a human-hamster hybrid cell line. J Cell Biochem (1992) 0.98
Chromosomal assignment of human YAC clones by fluorescence in situ hybridization: use of single-yeast-colony PCR and multiple labeling. Genomics (1992) 0.97
Multiple variants in subtelomeric regions of normal karyotypes. Genomics (1992) 0.96
Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes. Proc Natl Acad Sci U S A (2001) 0.95
A human homologue of the Drosophila polarity gene frizzled has been identified and mapped to 17q21.1. Genomics (1995) 0.95
Mapping human YAC clones by fluorescence in situ hybridization using Alu-PCR from single yeast colonies. Methods Mol Biol (1994) 0.95
A new method for identification of Trichomonas vaginalis by fluorescent DNA in situ hybridization. J Clin Microbiol (1994) 0.95
Identification of a putative regulatory subunit of a calcium-activated potassium channel in the dup(3q) syndrome region and a related sequence on 22q11.2. Genomics (1999) 0.93
A genetic etiology for interruption of the aortic arch type B. Am J Cardiol (1997) 0.93
Tobacco control activities of primary-care physicians in the Community Intervention Trial for Smoking Cessation. COMMIT Research Group. Tob Control (1997) 0.92
Haploinsufficiency of cytosolic serine hydroxymethyltransferase in the Smith-Magenis syndrome. Am J Hum Genet (1995) 0.92
Quadriceps-sparing versus mini-subvastus approach in total knee arthroplasty. Clin Orthop Relat Res (2006) 0.90
Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study. J Endocrinol Invest (2006) 0.90
Functional analysis of Gscl in the pathogenesis of the DiGeorge and velocardiofacial syndromes. Hum Mol Genet (1998) 0.90
Cloning and mapping of the mouse alpha 7-neuronal nicotinic acetylcholine receptor. Genomics (1995) 0.89
The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization. Genomics (1994) 0.88
Localization of the human prostate transglutaminase (type IV) gene (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization. Genomics (1995) 0.87
Cloning and chromosome mapping of human and chicken Iroquois (IRX) genes. Cytogenet Cell Genet (2001) 0.86
Cytologic demonstration of differential activity of rRNA gene clusters in different human tissues. Hum Genet (1985) 0.86
Localization of BRRN1, the human homologue of Drosophila barr, to 2q11.2. Genomics (1997) 0.85
Isolation and chromosomal mapping of genomic clones encoding the human fatty acid synthase gene. Genomics (1994) 0.85
Characterization and physical mapping in human and mouse of a novel RING finger gene in Xp22. Genomics (1998) 0.85
Structure and chromosomal locations of mouse steroid receptor coactivator gene family. In Vitro Cell Dev Biol Anim (1999) 0.84
Congenital heart defects and 22q11 deletions: which genes count? Mol Med Today (1998) 0.84
A critical review of research related to family physician-assisted smoking cessation interventions. Cancer Prev Control (1997) 0.84
Comparative mapping of the DiGeorge syndrome region in mouse shows inconsistent gene order and differential degree of gene conservation. Mamm Genome (1997) 0.84
Is the genetic basis of DiGeorge syndrome in HAND? Nat Genet (1999) 0.84
Patella resurfacing in total knee replacement: functional evaluation and complications. Knee Surg Sports Traumatol Arthrosc (2001) 0.84
Genetic dissection of the DiGeorge syndrome phenotype. Cold Spring Harb Symp Quant Biol (2002) 0.83
Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome. Am J Med Genet (1996) 0.83
The COMMIT dental model: tobacco control practices and attitudes. J Am Dent Assoc (1993) 0.83
DiGeorge anomaly and chromosome 10p deletions: one or two loci? Am J Med Genet (1997) 0.83
Generation and characterization of a human chromosome 9 cosmid library. Somat Cell Mol Genet (1992) 0.83
Three members of the human cystatin gene superfamily, AHSG, HRG, and KNG, map within one megabase of genomic DNA at 3q27. Cytogenet Cell Genet (1995) 0.83
Subchromosomal band interval mapping and ordering of DNA markers in the region 3q26.3-q27 involved in the dup(3q) syndrome. Genomics (1994) 0.82
Cloning and comparative mapping of a gene from the commonly deleted region of DiGeorge and Velocardiofacial syndromes conserved in C. elegans. Mamm Genome (1996) 0.82
ES2, a gene deleted in DiGeorge syndrome, encodes a nuclear protein and is expressed during early mouse development, where it shares an expression domain with a Goosecoid-like gene. Hum Mol Genet (1998) 0.82